RJA
NTBL

Raymond James & Associates’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Raymond James & Associates’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-314
Closed -$1K – 3686
2018
Q1 		$1K Buy
+314
New +$63.3K ﹤0.01% 3459

Other funds holding NTBL

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Raymond James & Associates's NTBL Position: Q4 2021 in Review

Raymond James & Associates sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2021, closing a stake of 362 shares — an estimated $26K sold.

Raymond James & Associates first reported a position in NTBL in Q3 2016 and held it in 20 quarters. The position peaked at $394K in Q4 2017. 26 funds tracked by Wall St. Rank hold NTBL as of Q4 2021.

  • Raymond James & Associates reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 362 Notable Labs, Ltd. Ordinary Shares shares in Q4 2021, an estimated $26K.
  • Raymond James & Associates first reported a position in Notable Labs, Ltd. Ordinary Shares in Q3 2016 and held it in 20 quarters.
  • Raymond James & Associates's Notable Labs, Ltd. Ordinary Shares position peaked at $394K in Q4 2017.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.